安賢園中國(00922.HK):諒解備忘錄失效
格隆匯 9 月 18日丨安賢園中國(00922.HK)公佈,於2020年3月14日,安賢園浙江與合夥人訂立諒解備忘錄,內容有關安賢園浙江可能透過注資方式投資於阜陽市天壽園陵園管理有限公司及其經營性公墓發展,惟須待訂立正式協議後,方可作實。根據諒解備忘錄,安賢園浙江與合夥人應於諒解備忘錄日期起計六個月內訂立正式協議。
於2020年9月13日前,安賢園浙江與合夥人並無訂立正式協議,原因為安賢園浙江與合夥人於該期間內經真誠磋商後,無法就正式協議的條款達成協議。因此,諒解備忘錄已於2020年9月13日失效及其訂約方將不再尋求投資於目標公司。董事會認為,終止諒解備忘錄將不會對集團的業務營運及財務狀況造成任何重大不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.